ivig

  1. John Mac

    Trial Report Effect on QoL of Therapeutic Plasmapheresis and Intravenous Immunoglobulins on a Population of ME/CFS Patients, 2025, Oesch-Regeni

    Full title: The Effect on Quality of Life of Therapeutic Plasmapheresis and Intravenous Immunoglobulins on a Population of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients with Elevated β-Adrenergic and M3-Muscarinic Receptor Antibodies—A Pilot Study...
  2. forestglip

    Preprint [...] Plasmapheresis in [ME/CFS] Patients with Elevated β-Adrenergic and M3-Muscarinic Receptor Antibodies – a Pilot Study, 2025, Oesch-Régeni et al

    Effect on Quality of Life of Therapeutic Plasmapheresis in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients with Elevated β-Adrenergic and M3-Muscarinic Receptor Antibodies – a Pilot Study Boglárka Oesch-Régeni, Nicolas Germann, Georg Hafer, Dagmar Schmid, Norbert Arn [Line breaks...
  3. Wyva

    Review Mechanisms and treatment progress of neurological diseases of COVID and L-C19 in children, 2025, Li et al

    Abstract Objective Although SARS-CoV-2 primarily targets the respiratory system, there is evidence that it can also infect the central nervous system, especially in children, leading to neurological symptoms and long-term consequences. It is imperative to summarize the possible mechanisms, main...
  4. SNT Gatchaman

    Preprint Analysis of 977 Long COVID Patients Reveals Prevalent Neuropathy and Association with Anti-Ganglioside Antibodies, 2025, Maguire et al.

    Analysis of 977 Long COVID Patients Reveals Prevalent Neuropathy and Association with Anti-Ganglioside Antibodies Cole Maguire; Kristina Kashyap; Elizabeth Williams; Aziz Rija; Maisey Schuler; Cheyenne Ahamed; Chumeng Wang; Aurelia Mena; Jeffrey Saniuk; Johanna Busch; Sara Austin; Mary Kelley...
  5. J

    IV IG: Intravenous immunoglobulin infusions

    My son, 13, with Long Covid and polyneuropathy has been receiving intensive immunoglobulin infusion therapy (IVIG) since January 25. Previously Bell 10 for a year, now within 2 months it has risen to Bell 50, and the trend is rising. PEM almost no longer exists. He can hardly believe his luck -...
  6. Andy

    Review A review of intravenous immunoglobulin in the treatment of neuroimmune conditions, acute COVID-19 infection, and [LC]... 2024 Melamed et al

    Full title: A review of intravenous immunoglobulin in the treatment of neuroimmune conditions, acute COVID-19 infection, and post-acute sequelae of COVID-19 Syndrome Highlights IVIG has demonstrated efficacy in over 100 disorders, spanning hematologic, inflammatory, autoimmune, and infectious...
  7. SNT Gatchaman

    Review Autoimmunity in Syndromes of Orthostatic Intolerance: An Updated Review, 2024, Pena, Grubb et al.

    Autoimmunity in Syndromes of Orthostatic Intolerance: An Updated Review Pena, Clarissa; Moustafa, Abdelmoniem; Mohamed, Abdel-Rhman; Grubb, Blair Orthostatic intolerance is a broad term that represents a spectrum of dysautonomic disorders, including postural orthostatic tachycardia syndrome...
  8. Sid

    Trial Report Randomized controlled trial of intravenous immunoglobulin for autoimmune postural orthostatic tachycardia syndrome (iSTAND)

    Abstract Objective: This study assesses response to intravenous immunoglobulin (IVIG) in presumed autoimmune postural orthostatic tachycardia syndrome (POTS). Background: POTS may be associated with autoimmune disorders, serum autoantibodies, or recent infection. Uncontrolled case studies...
  9. Andy

    Children With PANS May Manifest POTS, 2022, Chan et al

    Objectives: Pediatric acute-onset neuropsychiatric syndrome (PANS) is characterized by an abrupt-onset of severe psychiatric symptoms including OCD, anxiety, cognitive difficulties, and sleep issues which is thought to be a post-infection brain inflammatory disorder. We observed postural...
  10. Sly Saint

    Back to the Future? Immunoglobulin Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, 2021, Brownlie and Speight

    Abstract The findings of controlled trials on use of intravenous immunoglobulin G (IV IgG) to treat myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are generally viewed as representing mixed results. On detailed review, a clearer picture emerges, which suggests that the potential...
  11. Andy

    Skewing of the B cell receptor repertoire in myalgic encephalomyelitis/chronic fatigue syndrome, 2021, Sato et al

    Highlights • ME/CFS is characterized by skewed B cell receptor gene usage. • Upregulation of specific IGHV genes correlated to infection-related episodes at onset. • Plasmablasts of ME/CFS patients upregulated interferon response genes. • B cell receptor repertoire analysis can provide a useful...
  12. veganmua

    Is IVIG treatment possible in the UK?

    If so, how to get it and from whom?
  13. adreno

    Successful treatment of POTS and MCAS using LDN, immunoglobulin and antibiotics

    Abstract A patient with severe postural orthostatic tachycardia syndrome (POTS) and mast cell activation syndrome (MCAS) received immunotherapy with low-dose naltrexone (LDN) and intravenous immunoglobulin (IVIg) and antibiotic therapy for small intestinal bacterial overgrowth (SIBO). A dramatic...
Back
Top Bottom